Copyright
©The Author(s) 2017.
World J Gastroenterol. May 14, 2017; 23(18): 3195-3204
Published online May 14, 2017. doi: 10.3748/wjg.v23.i18.3195
Published online May 14, 2017. doi: 10.3748/wjg.v23.i18.3195
Table 1 Indications for liver transplantation in patients with hepatocellular carcinoma according to current guidelines
| International society | Year | Listing criteria | Downstaging | Ref. |
| American Association for | 2010 | Milan criteria | No | [12] |
| the Study of Liver Diseases (AASLD) for hepatocellular carcinoma | ||||
| American Association for | 2013 | Milan criteria | Yes | [13] |
| the Study of Liver Diseases (AASLD) for liver transplant | ||||
| European Association for the Study of the Liver (EASL), European Organisation For Research And Treatment Of Cancer (EORTC) | 2011 | Milan criteria | No | [14] |
| European Society for Medical Oncology (ESMO), European Society of Digestive Oncology (ESDO) | 2012 | Milan criteria | No | [15] |
| Asian Pacific Association for the Study of the Liver (APASL) | 2010 | Milan criteria | No | [16] |
| Japan Society of Hepatology (JSH) | 2014 | Milan criteria | No | [17] |
| American Hepato-Pancreato-Biliary Association (AHPBA) | 2010 | Milan criteria | Yes | [18] |
| International Consensus Conference | 2010 | Milan criteria | Yes | [19] |
- Citation: Biolato M, Marrone G, Miele L, Gasbarrini A, Grieco A. Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach. World J Gastroenterol 2017; 23(18): 3195-3204
- URL: https://www.wjgnet.com/1007-9327/full/v23/i18/3195.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i18.3195